➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Mallinckrodt
AstraZeneca
Johnson and Johnson
Express Scripts

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 4,810,388

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,810,388
Title: Portable intravenous solutions and water for injection apparatus and method
Abstract:A portable assembly of components that is designed to produce sterile, intravenous solutions and water for injection in the field, under combat conditions and from various sources of raw feedwater. A single frame supports the components of the invention consisting of a pair of manually operated pump handles, a peristaltic pump to which is engaged an inlet feed tube. The device has the ability to suck water from available feedwater sources or from a reserve bottle designed to hold a variety of liquids that may be introduced therein from any available source. Feedwater is pumped into the base of a filter module containing a coarse filter combined with a reserve osmosis filter for an initial prefiltering of the water. Purified water then passes through a carbon exchange column and subsequently an ion exchange column. At this point, ultrapure water is then passed through a sterilizing filter from which it passes through an IV spike in the form of sterile, non-pyrogenic water for injection. Prepackaged, large volume parenteral bags with premeasured dried medicines located inside are provided so that when connected to the IV spike, IV solutions can be created from the reconstituted medicines. The invention is portable, disposable, air dropable, and can produced 20 to 40 liters of sterile, non-pyrogenic intravenous solutions and water for injection prior to shut down by depletion of the filter system.
Inventor(s): Trasen; Ben (Littleton, CO)
Assignee:
Application Number:07/093,696
Patent Claims:see list of patent claims

Details for Patent 4,810,388

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Boehringer Ingelheim
Medtronic
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.